Teladoc Capital Expenditures vs Other Non Cash Items Analysis
| TDOC Stock | USD 10.34 0.01 0.1% |
Teladoc financial indicator trend analysis is much more than just breaking down Teladoc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Teladoc is a good investment. Please check the relationship between Teladoc Capital Expenditures and its Other Non Cash Items accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.
Capital Expenditures vs Other Non Cash Items
Capital Expenditures vs Other Non Cash Items Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Teladoc Capital Expenditures account and Other Non Cash Items. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Teladoc's Capital Expenditures and Other Non Cash Items is 0.43. Overlapping area represents the amount of variation of Capital Expenditures that can explain the historical movement of Other Non Cash Items in the same time period over historical financial statements of Teladoc, assuming nothing else is changed. The correlation between historical values of Teladoc's Capital Expenditures and Other Non Cash Items is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Expenditures of Teladoc are associated (or correlated) with its Other Non Cash Items. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Non Cash Items has no effect on the direction of Capital Expenditures i.e., Teladoc's Capital Expenditures and Other Non Cash Items go up and down completely randomly.
Correlation Coefficient | 0.43 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Capital Expenditures
Capital Expenditures are funds used by Teladoc to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Teladoc operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Other Non Cash Items
Most indicators from Teladoc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Teladoc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.The current year's Selling General Administrative is expected to grow to about 561.1 M. The current year's Tax Provision is expected to grow to about 718.2 K
| 2022 | 2023 | 2024 | 2025 (projected) | Interest Expense | 9.3M | 22.3M | 25.6M | 25.1M | Depreciation And Amortization | 270.6M | 351.3M | 404.0M | 424.2M |
Teladoc fundamental ratios Correlations
Click cells to compare fundamentals
Teladoc Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Teladoc fundamental ratios Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 17.8B | 17.7B | 4.3B | 4.4B | 5.1B | 4.9B | |
| Short Long Term Debt Total | 1.5B | 1.3B | 1.6B | 1.6B | 1.8B | 1.9B | |
| Other Current Liab | 178.6M | 169.1M | 324.5M | 257.0M | 295.6M | 310.3M | |
| Total Current Liabilities | 332.6M | 331.0M | 399.8M | 420.6M | 483.7M | 507.9M | |
| Total Stockholder Equity | 15.9B | 16.0B | 2.3B | 2.3B | 2.7B | 4.0B | |
| Other Liab | 33.2M | 106.2M | 81.1M | 56.4M | 64.9M | 38.6M | |
| Property Plant And Equipment Net | 75.2M | 74.0M | 71.5M | 72.1M | 82.9M | 87.1M | |
| Net Debt | 732.0M | 374.0M | 655.1M | 468.6M | 538.9M | 565.8M | |
| Retained Earnings | (992.7M) | (1.4B) | (15.0B) | (15.2B) | (13.7B) | (13.0B) | |
| Accounts Payable | 46.0M | 47.3M | 47.7M | 43.6M | 50.2M | 52.7M | |
| Cash | 733.3M | 893.5M | 918.2M | 1.1B | 1.3B | 1.4B | |
| Non Current Assets Total | 16.7B | 16.5B | 3.0B | 2.9B | 3.3B | 4.2B | |
| Non Currrent Assets Other | 18.4M | 20.7M | 48.5M | 80.3M | 92.3M | 96.9M | |
| Other Assets | 6.5M | 2.1K | 20.7M | 48.5M | 55.8M | 58.6M | |
| Long Term Debt | 1.4B | 1.2B | 1.5B | 1.5B | 1.8B | 1.9B | |
| Cash And Short Term Investments | 786.6M | 896.0M | 918.2M | 1.1B | 1.3B | 1.4B | |
| Net Receivables | 169.3M | 169.0M | 210.6M | 230.1M | 264.6M | 277.8M | |
| Good Will | 746.1M | 14.6B | 14.5B | 1.1B | 1.2B | 1.2B | |
| Common Stock Total Equity | 73K | 150K | 160K | 163K | 146.7K | 291.3K | |
| Common Stock Shares Outstanding | 90.5M | 156.9M | 161.5M | 164.6M | 189.3M | 198.7M | |
| Liabilities And Stockholders Equity | 17.8B | 17.7B | 4.3B | 4.4B | 5.1B | 4.9B | |
| Non Current Liabilities Total | 1.5B | 1.4B | 1.6B | 1.6B | 1.9B | 2.0B | |
| Other Current Assets | 94.5M | 87.4M | 130.3M | 105.8M | 121.7M | 127.7M | |
| Other Stockholder Equity | 16.9B | 17.5B | 17.4B | 17.6B | 20.2B | 21.2B | |
| Total Liab | 1.9B | 1.7B | 2.0B | 2.1B | 2.4B | 2.5B | |
| Property Plant And Equipment Gross | 75.2M | 74.0M | 71.5M | 131.8M | 151.6M | 159.2M | |
| Total Current Assets | 1.1B | 1.2B | 1.3B | 1.5B | 1.7B | 1.8B | |
| Accumulated Other Comprehensive Income | 18.5M | (6.3M) | (42.8M) | (37.0M) | (33.3M) | (31.6M) | |
| Intangible Assets | 2.0B | 1.9B | 1.8B | 1.7B | 1.9B | 2.0B | |
| Common Stock | 150K | 160K | 163K | 167K | 150.3K | 276.9K | |
| Property Plant Equipment | 10.3M | 28.6M | 74.0M | 29.6M | 34.1M | 19.4M | |
| Net Tangible Assets | 67.5M | (665.2M) | (368.7M) | (556.1M) | (500.5M) | (475.5M) | |
| Current Deferred Revenue | 52.4M | 75.6M | 90.5M | 95.7M | 110.0M | 115.5M | |
| Deferred Long Term Liab | 21.7M | 104.6M | 2.4M | 54.8M | 63.0M | 66.2M | |
| Short Term Debt | 54.0M | 26M | 13.6M | 10.8M | 12.4M | 15.8M | |
| Retained Earnings Total Equity | (507.5M) | (992.7M) | (1.4B) | (15.0B) | (13.5B) | (12.8B) | |
| Long Term Debt Total | 440.4M | 1.4B | 1.2B | 1.5B | 1.8B | 1.9B | |
| Capital Surpluse | 1.5B | 16.9B | 17.5B | 17.4B | 20.0B | 21.0B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Teladoc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Teladoc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Teladoc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Teladoc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teladoc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For information on how to trade Teladoc Stock refer to our How to Trade Teladoc Stock guide.You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teladoc. If investors know Teladoc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teladoc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.78) | Revenue Per Share | Quarterly Revenue Growth (0.03) | Return On Assets | Return On Equity |
The market value of Teladoc is measured differently than its book value, which is the value of Teladoc that is recorded on the company's balance sheet. Investors also form their own opinion of Teladoc's value that differs from its market value or its book value, called intrinsic value, which is Teladoc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teladoc's market value can be influenced by many factors that don't directly affect Teladoc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teladoc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teladoc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teladoc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.